Keyphrases
Abnormal Uterine Bleeding
23%
Actual Weight
23%
Anaphylaxis
23%
Aneurysm
23%
Anti-factor Xa
23%
Anti-FXa
26%
Bleeding
26%
CD30+
23%
Chemotherapy
23%
Clinical Outcomes
23%
Clotting Disorders
23%
Consumptive Coagulopathy
23%
Cutaneous Lymphoproliferative Disorders
23%
Disease Analysis
23%
Dose Capping
23%
Efficacy Study
23%
Evans Syndrome
23%
Expression Profiling
23%
F9 Gene
23%
Factor 9
58%
Factor VIII Gene
23%
Genetic Determinants
23%
Haemophilia with Inhibitors
23%
Hemophilia
87%
Hemophilia B
70%
Heterogeneous Disorder
23%
IgA Deficiency
23%
Immunogenicity
23%
Inhibitor Development
31%
Kaposiform Lymphangiomatosis
23%
Lymphomatoid Papulosis
23%
MiR-1246
23%
Newly Diagnosed
23%
Observational Cohort Study
26%
Pediatric
46%
Pediatric Population
34%
Pericardial Effusion
23%
Post-thrombotic Syndrome
23%
Selective Immunoglobulin M Deficiency
23%
Sickle Cell Disease
23%
Small ncRNAs
23%
Subhyaloid Hemorrhage
23%
Thrombotic
23%
Thrombotic Thrombocytopenic Purpura
23%
Tranexamic Acid
23%
Treatment-related
35%
Unfractionated Heparin
46%
Unruptured Intracranial Aneurysm
23%
Von Willebrand Disease
23%
Von Willebrand Factor Cleaving Protease
23%
Medicine and Dentistry
Adolescence
23%
Anaphylaxis
23%
Aneurysm
23%
Anticoagulation
14%
Arm
23%
Bleeding
100%
Bleeding Disorder
13%
Blood Clotting Factor 8
19%
Body Mass Index
7%
Body Weight
23%
Capping Phenomenon
23%
Coagulation Factor VIII
7%
Coagulopathy
23%
Cohort Study
23%
Diseases
32%
Disseminated Intravascular Coagulation
23%
Efficacy Study
23%
Evans Syndrome
23%
Factor IX
35%
Fibrinolytic Therapy
14%
Haemophilia A
58%
Haemophilia B
46%
Hematological Cancer
7%
Hemostat
35%
Heparin
23%
Immunoglobulin M Deficiency
23%
Immunological Tolerance
17%
Intracranial Aneurysm
23%
Lymph Duct
7%
Lymphangiomatosis
23%
Lymphomatoid Papulosis
15%
Lymphoproliferative Disease
23%
Magnetic Resonance Angiography
14%
Magnetic Resonance Imaging
14%
Memory B Cell
7%
Menorrhagia
23%
Patient with Hemophilia
35%
Pediatrics
51%
Pericardial Fluid
23%
Plasma Factor
13%
Pleura Effusion
15%
Post-Thrombotic Syndrome
23%
Quality of Life
39%
Rib Resection
14%
Sickle-Cell Disease
23%
Thrombus
9%
Tranexamic Acid
23%
Unruptured Intracranial Aneurysm
23%
Visual Impairment
9%
Von Willebrand Disease
23%